Kostmann R. Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria. Acta Paediatr Suppl. 1956 Feb. 45:1-78. [Medline].
Klein C, Grudzien M, Appaswamy G, Germeshausen M, Sandrock I, Schäffer AA, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet. 2007 Jan. 39(1):86-92. [Medline].
Boxer LA. Severe congenital neutropenia: genetics and pathogenesis. Trans Am Clin Climatol Assoc. 2006. 117:13-31; discussion 31-2. [Medline]. [Full Text].
Hickey MJ, Kubes P. Intravascular immunity: the host-pathogen encounter in blood vessels. Nat Rev Immunol. 2009 May. 9(5):364-75. [Medline].
Donadieu J, Fenneteau O, Beaupain B, Mahlaoui N, Chantelot CB. Congenital neutropenia: diagnosis, molecular bases and patient management. Orphanet J Rare Dis. 2011. 6:26. [Medline].
Klein C. Congenital neutropenia. Hematology Am Soc Hematol Educ Program. 2009. 344-50. [Medline].
Nanua S, Murakami M, Xia J, Grenda DS, Woloszynek J, Strand M. Activation of the unfolded protein response is associated with impaired granulopoiesis in transgenic mice expressing mutant Elane. Blood. 2011 Mar 31. 117(13):3539-47. [Medline].
Ward AC, Dale DC. Genetic and molecular diagnosis of severe congenital neutropenia. Curr Opin Hematol. 2009 Jan. 16(1):9-13. [Medline].
Boztug K, Klein C. Genetic etiologies of severe congenital neutropenia. Curr Opin Pediatr. 2011 Feb. 23(1):21-6. [Medline].
Xia J, Link DC. Severe congenital neutropenia and the unfolded protein response. Curr Opin Hematol. 2008 Jan. 15(1):1-7. [Medline].
Xia J, Bolyard AA, Rodger E, Stein S, Aprikyan AA, Dale DC. Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia. Br J Haematol. 2009 Nov. 147(4):535-42. [Medline].
Connelly JA, Choi SW, Levine JE. Hematopoietic stem cell transplantation for severe congenital neutropenia. Curr Opin Hematol. 2012 Jan. 19(1):44-51. [Medline]. [Full Text].
Putsep K, Carlsson G, Boman HG, Andersson M. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet. 2002 Oct 12. 360(9340):1144-9. [Medline].
Germeshausen M, Welte K, Ballmaier M. In vivo expansion of cells expressing acquired CSF3R mutations in patients with severe congenital neutropenia. Blood. 2009 Jan 15. 113(3):668-70. [Medline].
Zeidler C, Germeshausen M, Klein C, Welte K. Clinical implications of ELA2-, HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropenia. Br J Haematol. 2009 Feb. 144(4):459-67. [Medline].
Carlsson G, van't Hooft I, Melin M, et al. Central nervous system involvement in severe congenital neutropenia: neurological and neuropsychological abnormalities associated with specific HAX1 mutations. J Intern Med. 2008 Oct. 264(4):388-400. [Medline].
Klein C, Grudzien M, Appaswamy G, Germeshausen M, Sandrock I, Schäffer AA, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet. 2007 Jan. 39(1):86-92. [Medline].
Dong F, Brynes RK, Tidow N, Welte K, Löwenberg B, Touw IP. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med. 1995 Aug 24. 333(8):487-93. [Medline].
Horwitz MS, Duan Z, Korkmaz B, Lee HH, Mealiffe ME, Salipante SJ. Neutrophil elastase in cyclic and severe congenital neutropenia. Blood. 2007 Mar 1. 109(5):1817-24. [Medline]. [Full Text].
Person RE, Li FQ, Duan Z, Benson KF, Wechsler J, Papadaki HA. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet. 2003 Jul. 34(3):308-12. [Medline].
Carlsson G, Aprikyan AA, Tehranchi R, Dale DC, Porwit A, Hellström-Lindberg E. Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells. Blood. 2004 May 1. 103(9):3355-61. [Medline].
Boztug K, Appaswamy G, Ashikov A, Schäffer AA, Salzer U, Diestelhorst J. A syndrome with congenital neutropenia and mutations in G6PC3. N Engl J Med. 2009 Jan 1. 360(1):32-43. [Medline].
Choi LM, Guelcher C, Guerrera MF. Novel treatment for severe congenital neutropenia with pegfilgrastim. Blood. 2007 Dec 1. 110(12):4134. [Medline].
Fioredda F, Calvillo M, Lanciotti M, Lanza T, Giunti L, Castagnola E. Pegfilgrastim in children with severe congenital neutropenia. Pediatr Blood Cancer. 2010 Mar. 54(3):465-7. [Medline].
Lähteenmäki PM, Jahnukainen K, Pelliniemi TT, Kainulainen L, Salmi TT. Severe congenital neutropenia and pegfilgrastim. Eur J Haematol. 2009 Jan. 82(1):75-6. [Medline].
Beaupain B, Leblanc T, Reman O, Hermine O, Vannier JP, Suarez F. Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registry. Pediatr Blood Cancer. 2009 Dec. 53(6):1068-73. [Medline].
Salehi T, Fazlollahi MR, Maddah M, Nayebpour M, Tabatabaei Yazdi M, Alizadeh Z, et al. Prevention and Control of Infections in Patients with Severe Congenital Neutropenia; A Follow up Study. Iran J Allergy Asthma Immunol. 2012 Mar. 11(1):51-6. [Medline].
Carlsson G, Fasth A, Berglöf E, Lagerstedt-Robinson K, Nordenskjöld M, Palmblad J, et al. Incidence of severe congenital neutropenia in Sweden and risk of evolution to myelodysplastic syndrome/leukaemia. Br J Haematol. 2012 Aug. 158(3):363-9. [Medline].
Chao JR, Parganas E, Boyd K, Hong CY, Opferman JT, Ihle JN. Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons. Nature. 2008 Mar 6. 452(7183):98-102. [Medline].
Germeshausen M, Grudzien M, Zeidler C, et al. Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations. Blood. 2008 May 15. 111(10):4954-7. [Medline].
Hakki SS, Aprikyan AA, Yildirim S, et al. Periodontal status in two siblings with severe congenital neutropenia: diagnosis and mutational analysis of the cases. J Periodontol. 2005 May. 76(5):837-44. [Medline].
Smith BN, Ancliff PJ, Pizzey A, Khwaja A, Linch DC, Gale RE. Homozygous HAX1 mutations in severe congenital neutropenia patients with sporadic disease: a novel mutation in two unrelated British kindreds. Br J Haematol. Mar 2009. 144(5):762-70. [Medline].